[Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments against aggregation inhibitors].
D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control*; D010974:Platelet Aggregation / Q000187:drug effects*
D005343:Fibrinolytic Agents; D001241:Aspirin
Pro--Kontra: Aggregationshemmer in der Prophylaxe des Herzinfarktes. Argumente gegen Aggregationshemmer.